Jennifer Visich

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · British Journal of Ophthalmology · 2014 · 362 citations · Full text

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

Paul Rutgeerts, Richard N. Fedorak, Daan W. Hommes et al. · Gut · 2012 · 150 citations · Full text

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

Yanan Zheng, Devin B. Tesar, Lisa J. Benincosa et al. · mAbs · 2012 · 135 citations · Full text

Immunocytochemical Technique, Immunology, Pharmacotherapy +17

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency

Amy E. Lovejoy, Tom C. Reynolds, Jennifer Visich et al. · Blood · 2006 · 117 citations · Full text

Population Pharmacokinetics of Rituximab in Patients With Chronic Lymphocytic Leukemia

Jing Li, Jianguo Zhi, Michael Wenger et al. · The Journal of Clinical Pharmacology · 2012 · 77 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +14